Election of employee representatives to the Board of Directors of Novo Nordisk A/S
February 28 2022 - 12:06PM
Election of employee representatives to the Board of Directors of
Novo Nordisk A/S
Bagsværd, Denmark,
28 February
2022 – The employees in Novo Nordisk A/S
have completed the election of employee representatives to the
Board of Directors of Novo Nordisk A/S.
The following were elected for the next four years:
- Elisabeth Dahl Christensen (newly
elected)
- Liselotte Hyveled (newly
elected)
- Mette Bøjer Jensen (re-elected)
- Thomas Rantzau (re-elected)
As substitutes for the employee-elected board members, the
following were elected:
- Anders Kaae
- Karina Bonde Lenau
- Jesper Thorning
- Tanja Villumsen
The new employee-elected board members will join the Board of
Directors following the annual general meeting of Novo Nordisk A/S
on 24 March 2022. At the same time the current board members Anne
Marie Kverneland, who did not run for election, and Stig Strøbæk,
who was not re-elected, will resign.
About employee-elected board
membersAccording to the Danish Companies Act, the
employees of Novo Nordisk A/S are entitled to be represented by
half of the total shareholder-elected Board members.
Employee-elected board members serve for a statutory four-year term
and have the same rights, duties and responsibilities as
shareholder-elected board members.
Novo Nordisk is a leading global healthcare company, founded in
1923 and headquartered in Denmark. Our purpose is to drive change
to defeat diabetes and other serious chronic diseases such as
obesity and rare blood and endocrine disorders. We do so by
pioneering scientific breakthroughs, expanding access to our
medicines, and working to prevent and ultimately cure disease. Novo
Nordisk employs about 47,800 people in 80 countries and markets its
products in around 170 countries. Novo Nordisk's B shares are
listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the
New York Stock Exchange (NVO). For more information, visit
novonordisk.com, Facebook, Twitter, LinkedIn and YouTube.
Further information
Media: |
|
|
Mette Kruse
Danielsen |
+45 3079 3883 |
mkd@novonordisk.com |
Michael Bachner
(US) |
+1 609 664
7308 |
mzyb@novonordisk.com |
|
|
|
Investors: |
|
|
Daniel Muusmann
Bohsen |
+45 3075 2175 |
dabo@novonordisk.com |
Ann Søndermølle
Rendbæk |
+45 3075 2253 |
arnd@novonordisk.com |
David Heiberg
Landsted |
+45 3077 6915 |
dhel@novonordisk.com |
Jacob Martin
Wiborg Rode |
+45 3075
5956 |
jrde@novonordisk.com |
Mark Joseph Root
(US) |
+1 848 213
3219 |
mjhr@novonordisk.com |
Company announcement No 18 / 2022
- PR220228_Employee_election_BOD_2022
Novo Nordisk (TG:NOVC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Novo Nordisk (TG:NOVC)
Historical Stock Chart
From Jul 2023 to Jul 2024